Report Detail

Request for Sample of this report

Other Global Anti-CD68 Antibody Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4679797
    • |
  • 26 February, 2026
    • |
  • Global
    • |
  • 113 Pages
    • |
  • GIR
    • |
  • Other

According to our (Global Info Research) latest study, the global Anti-CD68 Antibody market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Anti-CD68 antibodies are useful reagents for the immunodetection of the protein encoded by the gene, CD68 molecule (CD68) in humans. It is widely used in applications such as immunofluorescence, flow cytometry, western blot and immunohistochemistry. Orthologs for CD68 have also been reported in other species, including mouse, rat, bovine, frog and chimpanzee. The canonical CD68 protein is 354 amino acids in length, 37.4 kDa in mass, and has a lysosomal and membrane subcellular localization. It is a member of the LAMP protein family. CD68 is often detected in cells in the blood and is a marker for certain immune cells. Post-translational modifications have been described, notably glycosylation. Synonyms for this protein include: GP110; LAMP4; SCARD1; macrosialin; CD68 antigen; macrophage antigen CD68.
The industry trend for Anti-CD68 Antibody reflects the growing interest and demand for studying macrophages and their functions in immunology and pathology. As research advancements continue to highlight the importance of macrophages in various diseases, there is a rising need for reliable and specific tools like Anti-CD68 Antibody for their identification and characterization. The trend is fueled by a deeper understanding of the intricate roles that macrophages play in tissue homeostasis, immune responses, and disease progression. The development and commercial availability of high-quality Anti-CD68 Antibodies, as well as their integration into diverse analytical platforms, contribute to the growth of this product"s market. Continued research and technological innovations further stimulate the industry trend by expanding the applications and therapeutic potential of Anti-CD68 Antibodies.
This report is a detailed and comprehensive analysis for global Anti-CD68 Antibody market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Anti-CD68 Antibody market size and forecasts, in consumption value ($ Million), 2021-2032
Global Anti-CD68 Antibody market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Anti-CD68 Antibody market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Anti-CD68 Antibody market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Anti-CD68 Antibody
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Anti-CD68 Antibody market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BosterBio, ProSci, Bioss, GeneTex, Thermo Fisher Scientific, Biorbyt, MyBioSource, Novus Biologicals, RayBiotech, NSJ Bioreagents, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Anti-CD68 Antibody market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Monoclonal Antibody
Polyclonal Antibody
Market segment by Application
Biotechnology
Medical
University
Others
Market segment by players, this report covers
BosterBio
ProSci
Bioss
GeneTex
Thermo Fisher Scientific
Biorbyt
MyBioSource
Novus Biologicals
RayBiotech
NSJ Bioreagents
LSBio
Abnova Corporation
BioLegend
Wuhan Fine Biotech
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Anti-CD68 Antibody product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Anti-CD68 Antibody, with revenue, gross margin, and global market share of Anti-CD68 Antibody from 2021 to 2026.
Chapter 3, the Anti-CD68 Antibody competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Anti-CD68 Antibody market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Anti-CD68 Antibody.
Chapter 13, to describe Anti-CD68 Antibody research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Anti-CD68 Antibody by Type
    • 1.3.1 Overview: Global Anti-CD68 Antibody Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Anti-CD68 Antibody Consumption Value Market Share by Type in 2025
    • 1.3.3 Monoclonal Antibody
    • 1.3.4 Polyclonal Antibody
  • 1.4 Global Anti-CD68 Antibody Market by Application
    • 1.4.1 Overview: Global Anti-CD68 Antibody Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Biotechnology
    • 1.4.3 Medical
    • 1.4.4 University
    • 1.4.5 Others
  • 1.5 Global Anti-CD68 Antibody Market Size & Forecast
  • 1.6 Global Anti-CD68 Antibody Market Size and Forecast by Region
    • 1.6.1 Global Anti-CD68 Antibody Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Anti-CD68 Antibody Market Size by Region, (2021-2032)
    • 1.6.3 North America Anti-CD68 Antibody Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Anti-CD68 Antibody Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Anti-CD68 Antibody Market Size and Prospect (2021-2032)
    • 1.6.6 South America Anti-CD68 Antibody Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Anti-CD68 Antibody Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 BosterBio
    • 2.1.1 BosterBio Details
    • 2.1.2 BosterBio Major Business
    • 2.1.3 BosterBio Anti-CD68 Antibody Product and Solutions
    • 2.1.4 BosterBio Anti-CD68 Antibody Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 BosterBio Recent Developments and Future Plans
  • 2.2 ProSci
    • 2.2.1 ProSci Details
    • 2.2.2 ProSci Major Business
    • 2.2.3 ProSci Anti-CD68 Antibody Product and Solutions
    • 2.2.4 ProSci Anti-CD68 Antibody Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 ProSci Recent Developments and Future Plans
  • 2.3 Bioss
    • 2.3.1 Bioss Details
    • 2.3.2 Bioss Major Business
    • 2.3.3 Bioss Anti-CD68 Antibody Product and Solutions
    • 2.3.4 Bioss Anti-CD68 Antibody Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Bioss Recent Developments and Future Plans
  • 2.4 GeneTex
    • 2.4.1 GeneTex Details
    • 2.4.2 GeneTex Major Business
    • 2.4.3 GeneTex Anti-CD68 Antibody Product and Solutions
    • 2.4.4 GeneTex Anti-CD68 Antibody Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 GeneTex Recent Developments and Future Plans
  • 2.5 Thermo Fisher Scientific
    • 2.5.1 Thermo Fisher Scientific Details
    • 2.5.2 Thermo Fisher Scientific Major Business
    • 2.5.3 Thermo Fisher Scientific Anti-CD68 Antibody Product and Solutions
    • 2.5.4 Thermo Fisher Scientific Anti-CD68 Antibody Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.6 Biorbyt
    • 2.6.1 Biorbyt Details
    • 2.6.2 Biorbyt Major Business
    • 2.6.3 Biorbyt Anti-CD68 Antibody Product and Solutions
    • 2.6.4 Biorbyt Anti-CD68 Antibody Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Biorbyt Recent Developments and Future Plans
  • 2.7 MyBioSource
    • 2.7.1 MyBioSource Details
    • 2.7.2 MyBioSource Major Business
    • 2.7.3 MyBioSource Anti-CD68 Antibody Product and Solutions
    • 2.7.4 MyBioSource Anti-CD68 Antibody Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 MyBioSource Recent Developments and Future Plans
  • 2.8 Novus Biologicals
    • 2.8.1 Novus Biologicals Details
    • 2.8.2 Novus Biologicals Major Business
    • 2.8.3 Novus Biologicals Anti-CD68 Antibody Product and Solutions
    • 2.8.4 Novus Biologicals Anti-CD68 Antibody Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Novus Biologicals Recent Developments and Future Plans
  • 2.9 RayBiotech
    • 2.9.1 RayBiotech Details
    • 2.9.2 RayBiotech Major Business
    • 2.9.3 RayBiotech Anti-CD68 Antibody Product and Solutions
    • 2.9.4 RayBiotech Anti-CD68 Antibody Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 RayBiotech Recent Developments and Future Plans
  • 2.10 NSJ Bioreagents
    • 2.10.1 NSJ Bioreagents Details
    • 2.10.2 NSJ Bioreagents Major Business
    • 2.10.3 NSJ Bioreagents Anti-CD68 Antibody Product and Solutions
    • 2.10.4 NSJ Bioreagents Anti-CD68 Antibody Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 NSJ Bioreagents Recent Developments and Future Plans
  • 2.11 LSBio
    • 2.11.1 LSBio Details
    • 2.11.2 LSBio Major Business
    • 2.11.3 LSBio Anti-CD68 Antibody Product and Solutions
    • 2.11.4 LSBio Anti-CD68 Antibody Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 LSBio Recent Developments and Future Plans
  • 2.12 Abnova Corporation
    • 2.12.1 Abnova Corporation Details
    • 2.12.2 Abnova Corporation Major Business
    • 2.12.3 Abnova Corporation Anti-CD68 Antibody Product and Solutions
    • 2.12.4 Abnova Corporation Anti-CD68 Antibody Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Abnova Corporation Recent Developments and Future Plans
  • 2.13 BioLegend
    • 2.13.1 BioLegend Details
    • 2.13.2 BioLegend Major Business
    • 2.13.3 BioLegend Anti-CD68 Antibody Product and Solutions
    • 2.13.4 BioLegend Anti-CD68 Antibody Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 BioLegend Recent Developments and Future Plans
  • 2.14 Wuhan Fine Biotech
    • 2.14.1 Wuhan Fine Biotech Details
    • 2.14.2 Wuhan Fine Biotech Major Business
    • 2.14.3 Wuhan Fine Biotech Anti-CD68 Antibody Product and Solutions
    • 2.14.4 Wuhan Fine Biotech Anti-CD68 Antibody Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Wuhan Fine Biotech Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Anti-CD68 Antibody Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Anti-CD68 Antibody by Company Revenue
    • 3.2.2 Top 3 Anti-CD68 Antibody Players Market Share in 2025
    • 3.2.3 Top 6 Anti-CD68 Antibody Players Market Share in 2025
  • 3.3 Anti-CD68 Antibody Market: Overall Company Footprint Analysis
    • 3.3.1 Anti-CD68 Antibody Market: Region Footprint
    • 3.3.2 Anti-CD68 Antibody Market: Company Product Type Footprint
    • 3.3.3 Anti-CD68 Antibody Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Anti-CD68 Antibody Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Anti-CD68 Antibody Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Anti-CD68 Antibody Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Anti-CD68 Antibody Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Anti-CD68 Antibody Consumption Value by Type (2021-2032)
  • 6.2 North America Anti-CD68 Antibody Market Size by Application (2021-2032)
  • 6.3 North America Anti-CD68 Antibody Market Size by Country
    • 6.3.1 North America Anti-CD68 Antibody Consumption Value by Country (2021-2032)
    • 6.3.2 United States Anti-CD68 Antibody Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Anti-CD68 Antibody Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Anti-CD68 Antibody Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Anti-CD68 Antibody Consumption Value by Type (2021-2032)
  • 7.2 Europe Anti-CD68 Antibody Consumption Value by Application (2021-2032)
  • 7.3 Europe Anti-CD68 Antibody Market Size by Country
    • 7.3.1 Europe Anti-CD68 Antibody Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Anti-CD68 Antibody Market Size and Forecast (2021-2032)
    • 7.3.3 France Anti-CD68 Antibody Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Anti-CD68 Antibody Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Anti-CD68 Antibody Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Anti-CD68 Antibody Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Anti-CD68 Antibody Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Anti-CD68 Antibody Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Anti-CD68 Antibody Market Size by Region
    • 8.3.1 Asia-Pacific Anti-CD68 Antibody Consumption Value by Region (2021-2032)
    • 8.3.2 China Anti-CD68 Antibody Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Anti-CD68 Antibody Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Anti-CD68 Antibody Market Size and Forecast (2021-2032)
    • 8.3.5 India Anti-CD68 Antibody Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Anti-CD68 Antibody Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Anti-CD68 Antibody Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Anti-CD68 Antibody Consumption Value by Type (2021-2032)
  • 9.2 South America Anti-CD68 Antibody Consumption Value by Application (2021-2032)
  • 9.3 South America Anti-CD68 Antibody Market Size by Country
    • 9.3.1 South America Anti-CD68 Antibody Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Anti-CD68 Antibody Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Anti-CD68 Antibody Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Anti-CD68 Antibody Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Anti-CD68 Antibody Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Anti-CD68 Antibody Market Size by Country
    • 10.3.1 Middle East & Africa Anti-CD68 Antibody Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Anti-CD68 Antibody Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Anti-CD68 Antibody Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Anti-CD68 Antibody Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Anti-CD68 Antibody Market Drivers
  • 11.2 Anti-CD68 Antibody Market Restraints
  • 11.3 Anti-CD68 Antibody Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Anti-CD68 Antibody Industry Chain
  • 12.2 Anti-CD68 Antibody Upstream Analysis
  • 12.3 Anti-CD68 Antibody Midstream Analysis
  • 12.4 Anti-CD68 Antibody Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Anti-CD68 Antibody. Industry analysis & Market Report on Anti-CD68 Antibody is a syndicated market report, published as Global Anti-CD68 Antibody Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Anti-CD68 Antibody market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo